References
- Godfraind T, Miller R, Wibo M. Calcium antagonisms and calcium entry blockade. Pharmacol. rev. 1986; 38: 321–416
- Supavilai P, Karobath M. The interaction of 3H PY 108–068 and of [3H]PN 200–110 with calcium channel binding sites in rat brain. J. Neural Transmission 1984; 60: 149–167
- Grotta J C, Pettigrew L C, Lockwood A H, Reich C. Brain extraction of a calcium channel blocker. Ann. Neurol. 1987; 21: 171–175
- Murphy K MM, Snyder S H. Calcium antagonist receptor binding sites labeled with 3H nitrendipine. Eur. J. Pharmacol. 1982; 77: 201–202
- Ishii K, Kano T, Ando J, Yoshida H. Binding of 3H nitrendipine to cardiac and cerebral membranes from normotensive and renal, deoxycorticosterone/NaCl and spontaneously hypertensive rats. Eur. J. Pharmacol. 1986; 123: 271–278
- Middlemiss D N, Spedding M. A functional correlate for the dihydropyridine binding site in rat brain. Nature (London) 1985; 314: 94–96
- Turner T J, Goldin S M. Calcium channels in rat brain synaptosomes: identification and pharmacological characterization. J. Neurosci. 1985; 5: 841–849
- Laurent S, Girerd X, Tsoucaris-Kupfer D, Legrand M, Huchet-Brisac A M. Schmitt Opposite central cardiovascular effects of nifedipine and BAY K 8644 in anesthetized rats. Hypertension 1987; 9: 132–138
- Brisac A M, Huguet F, Champeroux P, Montastruc J L, Lucet B, Gerard P, Laurent S, Narcisse G, Schmitt H. Central interactions between dihydropyridines and cholinergic systems in the control of blood pressure in rat. Brain Research 1987; 160: 435–441
- Laurent S, Brisac A M, Champeroux P, Lacolley P, Huguet F, Legrand M, Lucet M, Tsoucaris D, Briand V, Schmitt H. Central cardiovascular effects of dihydropyridines in spontaneously hypertensive rats. Fundam. Clin. Pharmacol. 1989; 3: 47S–57S